Pamela Bassett Joins Cantor Fitzgerald As Life Sciences Equity Research Analyst

New York, NY – April 18, 2006 – Cantor Fitzgerald & Co., a leading global financial services provider to the institutional equity and fixed-income markets, today announced that Pamela Bassett, D.M.D., has joined the Firm’s New York office as an Equity Research Analyst covering the life sciences sector. In her new role at Cantor, Dr. Bassett will publish research on companies involved in biotechnology, pharmaceuticals, medical devices, and diagnostics. [br][br]Prior to joining Cantor Fitzgerald, Dr. Bassett was the founder and President of BioTrend Corporation, which provided strategic advisory services to both multi-national pharmaceutical companies and U.S., Canadian and European biopharmaceutical companies. Dr. Bassett was formerly Director of Business Development for Enzon, and prior to that, provided advisory services to technology (telecom, software, biotech) companies on new wwwuct and emerging market development. She was also the founder and President of Stat Systems, Inc., a company that developed a first-in-class integrated clinical and administrative software system used in hospitals nationwide, ultimately licensed to Siemens AG. [br][br]“We are excited that Pamela has joined our equity research team,” said Phil Marber, President and CEO of Cantor Fitzgerald’s Equity Capital Markets Group. “Her broad knowledge of the biotech and life sciences industry sector coupled with her extensive industry experience will play an important role as we continue to expand our business and look to offer our institutional clients value added research.” [br][br]“I am pleased to join Cantor Fitzgerald’s growing equity research team,” said Dr. Bassett. “Cantor has a tremendous institutional trading and distribution platform and I look forward to working with the Firm to build the life sciences research group.” [br][br]Dr. Bassett has published extensively on emerging technologies and business strategies in biopharmaceuticals. She received her M.B.A. from Wharton Graduate School, University of Pennsylvania, completed a Residency in Anesthesiology at the Medical College of Pennsylvania and Hospital, and received her D.M.D. from Tufts University School of Dental Medicine and a B.A. in Biology from Oakland University. [br][br]About Cantor Fitzgerald [br][br]Cantor Fitzgerald, & Co. is a leading financial services provider to the institutional equity and fixed income markets, with wwwucts and services including sales and trading, investment banking, asset management, market data, and market commentary. For nearly 60 years, Cantor Fitzgerald, a proven and resilient leader, has been committed to delivering a unique brand of unparalleled trading and distribution services, wwwuct expertise, innovative technology and customer service to its clients around the world. This commitment also extends to numerous philanthropic endeavors, including the firm’s pledge to donate 25% of the profits it would otherwise distribute to its partners through 2006 to benefit the families of the employees lost on September 11, 2001. For more information, please visit aws-dev1.cantor.com. [br][br]Media Contacts: [br][br]Tristan Peniston-Bird – New York Gavin Anderson & Company 212-515-1933 [br][br]tpeniston-bird@gavinanderson.com [br][br]Adrian Thomas – London 44-207-894-8647 [br][br]athomas@cantor.com

 

 


View PDF PDF version